Repros Therapeutics, Inc. (RPRX)

[rstor1]

You guys are pretty funny. If I were Dew, I would be flattered by the flurry of responses.

Since when is the "slam-dunk meter" a benchmark in bio investing?

Dew has opinions. They are generally well thought out, but they are opinions. Take them as such. You might give them more or less credence than you would someone else's opinion, but they are not hard facts.

BTW, I'm not sure of the relevance of the GTCB performance to Repros or to Dew's credibility - we've all had uderperforming investments.

Regards,
Bob